There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

The US Food and Drug Administration issued a draft guidance, Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches.

FDA Issues Draft Guidance of Genotoxic Impurities

Also, BASF opens lab in Mumbai; Evotek president and CEO to resign; more...

Company and People Notes: Hovione to Acquire Pfizer API site; Xceleron Appoints Michael Butler President and CEO; More...

At its annual business briefing held last week, Merck & Co. outlined its short- and long-term strategy for growth. Its strategy is focused on increased penetration in emerging markets, the establishment of a business for developing follow-on biologics or biosimilars, and a new commercial model for product life-cycle management.

Merck Forms Follow-On Biologics Business; Emphasizes Emerging Markets

PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the December 2008 edition from Spiroflow Systems and Sepha.

December 2008 Editor's Picks: Products from Spiroflow Systems and Sepha

Also, NicOx and DSM make manufacture and supply pact for naproxcinod drug substance; NovaRx appointed Norrie Russell president and COO; more...

Company and People Notes: BMS and AstraZeneca Expand Collaboration; Johnathan Knowles to Retire from Roche in 2009; More...

A Centers for Disease Control and Prevention (CDC) study confirmed that severe adverse reactions reported in the fall and winter of 2007 resulted from heparin contaminated with oversulfated chondroitin sulfate (OSCS).

CDC Identifies Cause of Heparin-Related Reactions

Also, AstraZeneca announces changes to its supply chain operations; Christian Velmer appointed head of Wyeth Canada; More...

Company and People Notes: Lilly Completes Acquisition of ImClone; Novocell CEO to Lead The Juvenile Diabetes Research Foundation; More...

Mohamed Etman is a professor of pharmaceutics at the Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

Hala Nada is the R&D manager at the European Egyptian Company for Pharmaceuticals, Alexandria, Egypt.

Aly Nada is an associate professor and chairman at the Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, PO Box 24923 Safat, 13110 Kuwait, tel. 00965 4986072, fax: 00965 4986843, 

Fatma Ismail is a professor at the Faculty of Pharmacy, Alexandria University.

Mamdouh Moustafa is a professor and consultant at Arab Company for Drug Industries and Medical Appliances (ACDIMA), Cairo, Egypt.

Said Khalil is a professor at the Faculty of Pharmacy, Alexandria University.

The authors evaluated the effect of polymer composition on the drug-release profile and the effect of storage conditions on dissolution characteristics.

Formulation of Sustained-Release Ketorolac Tromethamine Pellets

The past year saw major acquisitions attempted, completed, rejected, and stalled.

Billion-Dollar Deals of 2008

Readers provide insight into the best companies to work for as well as the ups and downs of their jobs.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes